Skip to main content

Table 10 Meta-analysis – Survival in 15 trials comparing gemcitabine to gemcitabine + cytotoxic agent

From: Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

Groups

n trials

n patients

HR

p

95% CI

Gemcitabine versus Gemcitabine + Platinum Analog

5

1248

0.85

0.010

0.76 – 0.96

Gemcitabine versus Gemcitabine + Fluoropyrimidine

6

1813

0.90

0.03

0.81 – 0.99

Gemcitabine versus Gemcitabine + other cytotoxic agent

4

1404

0.99

0.80

0.88 – 1.10

Total

15

4465

0.91

0.004

0.85 – 0.97